Preview: Kymera Therapeutics's Earnings
Portfolio Pulse from Benzinga Insights
Kymera Therapeutics (NASDAQ:KYMR) is set to release its quarterly earnings report on November 2, 2023. Analysts estimate an EPS of $-0.72. The company's past performance shows a pattern of share price drops following earnings reports, with a 5.49% drop after the last quarter's report. The company's shares are currently trading at $11.67, down 63.13% over the last 52-week period.
November 01, 2023 | 5:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Kymera Therapeutics is expected to report an EPS of $-0.72. The company's stock has historically dropped following earnings reports. The stock is currently down 63.13% over the last 52 weeks.
Kymera Therapeutics has a history of its stock price dropping following earnings reports. Given the analysts' estimate of a negative EPS, it is likely that the stock price will be negatively impacted in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100